“Beyond the Knife”—Applying Theranostic Technologies to Enhance Outcomes in Neurosurgical Oncology
2024

Using New Technologies to Improve Brain Tumor Surgery

publication Evidence: moderate

Author Information

Author(s): Guru Santosh, Lam Fred C., Akhavan-Sigari Amirhossein, Hori Yusuke S., AbuReesh Deyaaldeen, Tayag Armine, Emrich Sara C., Ustrzynski Louisa, Park David J., Chang Steven D.

Primary Institution: Stanford University School of Medicine

Hypothesis

Can theranostic technologies enhance outcomes in neurosurgical oncology?

Conclusion

Innovative imaging and therapeutic technologies can significantly improve the precision of brain tumor surgeries and patient outcomes.

Supporting Evidence

  • Fluorescence-guided surgery improves tumor visualization and resection.
  • Theranostic nanoparticles can enhance drug delivery across the blood-brain barrier.
  • Targeted imaging agents can help differentiate tumor tissue from healthy tissue during surgery.
  • Nanoparticle-based therapies may reduce systemic toxicity while improving treatment efficacy.

Takeaway

Doctors are using special tools and techniques to see and treat brain tumors better, which helps patients live longer and healthier lives.

Methodology

The article reviews advancements in image-guided neurosurgery and stereotactic radiosurgery, focusing on theranostic nanoparticles for targeted treatment.

Potential Biases

Potential biases in the studies reviewed may affect the generalizability of the findings.

Limitations

The review highlights the challenges in translating preclinical findings to clinical practice and the potential immunogenicity of some therapies.

Digital Object Identifier (DOI)

10.3390/brainsci14121253

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication